Dina Lev
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Sarcoma Diagnosis and Treatment
- Rheumatology top 0.2%
- Soft tissue tumor case studies
- Bone Tumor Diagnosis and Treatments
Papers in
-
- Sarcoma Diagnosis and Treatment 78
-
- Histone Deacetylase Inhibitors Research 8
- Co-authors
- Alexander J. Lazar (102 shared papers)Raphael E. Pollock (88 shared papers)Guy Lahat (30 shared papers)Svetlana Bolshakov (24 shared papers)Menashe Bar‐Eli (9 shared papers)Wei‐Lien Wang (22 shared papers)Peter W. T. Pisters (13 shared papers)Daniel Tuvin (8 shared papers)
- Journals
- Cancer Research (17 papers)Clinical Cancer Research (17 papers)Cancer (14 papers)Annals of Surgical Oncology (12 papers)Modern Pathology (6 papers)
- Partner nations
- United StatesIsraelAustralia
In The Last Decade
Dina Lev
178 papers receiving 9.3k citations
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 4.1k
- Rheumatology 1.7k
- Oncology 2.7k
- Cancer Research 1.1k
- Neurology 995
Countries citing papers authored by Dina Lev
This map shows the geographic impact of Dina Lev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Lev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Lev more than expected).
Fields of papers citing papers by Dina Lev
This network shows the impact of papers produced by Dina Lev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Lev. The network helps show where Dina Lev may publish in the future.
Co-authors
The 25 scholars most cited alongside Dina Lev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 344 | |
| 2 | 2013 | 247 | |
| 3 | 2009 | 233 | |
| 4 | 2007 | 214 | |
| 5 | 2010 | 205 | |
| 6 | 2009 | 177 | |
| 7 | 2004 | 177 | |
| 8 | 2010 | 165 | |
| 9 | 2017 | 151 | |
| 10 | 2008 | 141 | |
| 11 | 2013 | 141 | |
| 12 | 2013 | 132 | |
| 13 | 2002 | 129 | |
| 14 | 2010 | 124 | |
| 15 | 2008 | 116 | |
| 16 | 2004 | 112 | |
| 17 | 2009 | 111 | |
| 18 | 2007 | 108 | |
| 19 | 2015 | 106 | |
| 20 | 2012 | 105 |
About Dina Lev
Dina Lev is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Rheumatology and Cancer Research, having authored 181 papers that have together received 9.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (78 papers), Vascular Tumors and Angiosarcomas (20 papers), Soft tissue tumor case studies (16 papers), Neurofibromatosis and Schwannoma Cases (14 papers), Histone Deacetylase Inhibitors Research (8 papers), MicroRNA in disease regulation (7 papers), Cardiac tumors and thrombi (6 papers) and Tumors and Oncological Cases (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.1k citations), Rheumatology (1.7k citations), Oncology (2.7k citations), Cancer Research (1.1k citations) and Neurology (995 citations). Dina Lev has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include Alexander J. Lazar, Raphael E. Pollock, Guy Lahat, Svetlana Bolshakov, Menashe Bar‐Eli, Wei‐Lien Wang, Peter W. T. Pisters, Daniel Tuvin, Janet E. Price and Dolores López‐Terrada. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Cancer, Annals of Surgical Oncology and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.